OakChart

Balchem Corp

BCPCBasic Materials·Specialty Chemicals·USA·Mid·NASD·Nov 12 • 3:59 PM ET

172.35-0.95 (-0.55%)
2026-11-13 13:14 CET
Market cap
$5.48B
Revenue, TTM
1,108.98 USD m
Net income, TTM
170.85 USD m
Free cash flow, TTM
178.00 USD m
EPS diluted, TTM
5.31
32.48
Compare

Price

BCPC against its 20, 50 and 200-day averages
Terms2050200Beat
Patternshover a marker to name it
RS 16Sales 287Price284287160.00170.00180.00381K761KVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26BCPCclose 172.3520-day 173.0950-day 169.83200-day 169.65172.3552w high 186.1552-week range, not 6 months

7.4% under the 52-week high of 186.15 on 5 Nov 2026. 52-week low 147.18 on 9 Dec 2025. Last 15 sessions, 12.3% high to low

Volume 0.00× normal · the session has not printed · the line is the 50-bar volume average

Setup. RS line 16
CANSLIM 3 of 6 — fails: EPS Growth Qtr Over Qtr: High (>25%); EPS Growth This Year: High (>25%); Performance: Year +50%
VCP 5 of 6 — fails: Average True Range: Under 2
Minervini 3 of 4 — fails: Performance: Year +50%
Zanger 1 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5
Leaders 3 of 5 — fails: Performance: Year +50%; Average Volume: Over 500K
Breakout 2 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2
Growth 0 of 4 — fails: EPS Growth Qtr Over Qtr: High (>25%); EPS Growth This Year: High (>25%); EPS Growth Next Year: High (>25%); Return on Equity: Over +15%
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1); P/E: Under 25
Value 0 of 4 — fails: P/E: Under 15; P/B: Under 2; Return on Equity: Over +15%; Debt/Equity: Low (<0.1)
Income 1 of 4 — fails: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 2 of 4 — fails: Average Volume: Over 500K; Performance: Year +50%
Accumulation 3 of 4 — fails: Institutional Transactions: Over +10%
Relative Strength 1 of 3 — fails: Performance: Year +100%; Average Volume: Over 500K

Profile

BCPC
52-week range, 65% of the way up
147.18186.15

Balchem Corp. markets specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems. The Animal Nutrition and Health segment consists of nutritional products derived from microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment offers Ethylene oxide for the health care industry. The company was founded in 1967 and is headquartered in Montvale, NJ.

IndexRUT
Employees1352
IPOJun 03, 1986
Beta0.85
ATR, 14d4.38
Rel volume0.00
Short float1.59%
Insider own0.55%
Inst own90.47%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap$5.48B
Enterprise Value5.55B
Income170.85M
Sales1.11B
Book / share41.69
Cash / share2.09
Dividend Est.1.18 (0.69%)
Dividend TTM0.96 (0.56%)
Dividend Ex-DateDec 23, 2025
Dividend Gr. 3/5Y10.58% 10.60%
Payout20.21%
Employees1352
IPOJun 03, 1986

Ratios

Price / earnings32.48
Forward price / earnings30.15
Price / earnings / growth4.03
Price / sales4.94
Price / book4.13
Price / cash82.66
Price / free cash flow30.77
Value / cash profit19.34
Value / sales5.01
Quick Ratio1.39
Current Ratio2.47
Debt / equity0.11
Long-term debt / equity0.10
Options and shortYes / Yes

Earnings

Earnings / share5.31
Earnings next year5.72
Earnings next quarter1.41
Earnings this year15.37%
Earnings next year4.32%
Earnings growth, 5 years7.49%
Past earnings growth13.45% 12.78%
Past sales growth3.25% 8.07%
Earnings vs last year16.31%
Sales vs last year9.42%
Earnings vs last quarter18.02%
Sales vs last quarter8.63%
EarningsOct 23 BMO
Surprise2.10% 0.49%

Ownership

Insiders own0.55%
Insider trades0.00%
Institutions own90.47%
Institution trades0.50%
Return on assets10.16%
Return on equity13.02%
Return on capital11.66%
Gross Margin36.46%
Operating margin21.54%
Profit Margin15.41%
20-day average-0.43%
50-day average1.48%
200-day average1.59%

Technical

Shares out31.82M
Shares floating31.60M
Short / float1.59%
Short ratio2.05
Short interest0.50M
52-week high186.15 -7.4%
52-week low147.18 +17.1%
Volatility2.33% 2.38%
Average range4.38
Strength index49.68
Market sensitivity0.85
Relative volume0.00
Avg Volume245.73K
Volume0

Performance

Perf Week-4.10%
Perf Month1.11%
Perf Quarter-3.45%
Perf Half Y6.99%
Perf YTD12.38%
Perf Year9.63%
Perf 3Y45.68%
Perf 5Y4.29%
Perf 10Y121.22%
Recommendation1.50
Target Price213.50
Prev Close172.35
Price172.35
Change %0.00%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Dec 05, 2025InitiatedRothschild & Co RedburnNeutral$162-6.0%
Feb 22, 2022UpgradeSidotiNeutral → Buy$175+1.5%
Nov 29, 2021DowngradeSidotiBuy → Neutral$175+1.5%
Aug 02, 2021DowngradeStephensOverweight → Equal-Weight$140 → $145-15.9%
Feb 22, 2021UpgradeStephensEqual-Weight → Overweight
Aug 04, 2020ReiteratedH.C. WainwrightBuy$104 → $126-26.9%
Jul 10, 2020InitiatedStephensEqual-Weight$100-42.0%
Feb 24, 2020ReiteratedH.C. WainwrightBuy$122 → $116-32.7%
May 06, 2019DowngradePivotal Research GroupBuy → Hold$100-42.0%
Feb 21, 2019InitiatedSeaport Global SecuritiesNeutral

Peers

Mkt cap
TickerCompanyMkt cap
SXTSensient Technologies Corp4.92B
IFFInternational Flavors & Fragrances Inc20.13B
ASHAshland Inc3.45B
HWKNHawkins Inc3.13B
IOSPInnospec Inc1.96B
INGRIngredion Inc5.78B
KWRQuaker Houghton2.64B
PAHCPhibro Animal Health Corp1.44B
DARDarling Ingredients Inc8.58B
ADMArcher Daniels Midland Co33.79B

Insider trading

7 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Fischer David BDirectorDec 03 '25Option Exercise78.726,000472,33415,989Dec 05 04:28 PM
Fischer David BDirectorDec 03 '25Sale153.978,0001,231,7487,989Dec 05 04:28 PM
van Gunsteren Job LeonardSVP and GM, Specialty ProductsDec 04 '25Option Exercise60.856,000365,10015,446Dec 05 04:23 PM
van Gunsteren Job LeonardSVP and GM, Specialty ProductsDec 04 '25Sale153.296,000919,7239,446Dec 05 04:23 PM
van Gunsteren Job LeonardOfficerDec 04 '25Proposed Sale153.296,000919,722Dec 04 05:08 PM
Fischer David BDirectorDec 03 '25Proposed Sale153.916,000923,458Dec 03 05:05 PM
Fischer David BDirectorDec 03 '25Proposed Sale154.202,000308,400Dec 03 05:03 PM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 107.13B
VTIVanguard Morningstar Total Stock Market ETFAUM: 696.31B
IWMiShares Russell 2000 Index FundAUM: 77.86B
VBVanguard Morningstar Small-Cap ETFAUM: 80.23B
SDVYFirst Trust SMID Cap Rising Dividend Achievers ETFAUM: 11.36B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.68B
VXFVanguard Extended Market Index ETFAUM: 30.79B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.19B
IWOiShares Russell 2000 Growth ETFAUM: 14.25B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.64B

News

latest 14 of 200
  • Balchem Corporation to Participate in Baird's Global Industrial Conference on November 11, 2026 (GlobeNewswire)
  • Balchem's Record Q3 Beats On Margins And Cash Flow, But Cooling Sales Growth Is The Tension To Watch (Earnings Whispers)
  • Balchem Corporation Reports Third Quarter 2026 Financial Results (GlobeNewswire)
  • Balchem Corporation Announces Quarterly Conference Call for Third Quarter 2026 Financial Results on October 23, 2026 (GlobeNewswire)
  • Balchem Corporation to Participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026 (GlobeNewswire)
  • Beyond Oil: Record Revenue & U.S. Direct-Sales Expansion Fuel Scaling Phase Quarterly Update Report (Exec Edge)
  • Balchem Corp (BCPC) (Q2 2026) Earnings Call Highlights: Record Sales and 28th Consecutive ... (GuruFocus.com)
  • Balchem Corporation Reports Second Quarter 2026 Financial Results (GlobeNewswire)
  • Balchem Corporation Announces Quarterly Conference Call for Second Quarter 2026 Financial Results on July 31, 2026 (GlobeNewswire)
  • Balchem Corporation to Participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026 (GlobeNewswire)
  • Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026 (GlobeNewswire)
  • Balchem Corporation Reports First Quarter 2026 Financial Results (GlobeNewswire) -6.76%
  • Balchem Corporation: The Formulation-Embedded Compounder That Has Not Missed a Year (GuruFocus.com)
  • Balchem Corporation Releases 2025 Sustainability Report (GlobeNewswire)

Quarterly earnings

2026Q3 EPS 1.460 beat 1.430, from 1.240 a year earlier. Sales 290.66 beat 289.25, from 267.56 a year earlier
EPS
1.46002024Q4 EPS 1.030 against 1.05524Q42025Q1 EPS 1.130 against 1.04525Q12025Q2 EPS 1.170 against 1.12025Q22025Q3 EPS 1.240 against 1.15525Q32025Q4 EPS 1.210 against 1.17525Q42026Q1 EPS 1.250 against 1.24526Q12026Q2 EPS 1.390 against 1.27526Q22026Q3 EPS 1.460 against 1.43026Q3
Sales, USD millions
290.6602024Q4 sales 240 against 239.9624Q42025Q1 sales 250.52 against 245.725Q12025Q2 sales 255.47 against 250.3125Q22025Q3 sales 267.56 against 258.2825Q32025Q4 sales 263.62 against 259.5925Q42026Q1 sales 270.71 against 266.526Q12026Q2 sales 284 against 268.526Q22026Q3 sales 290.66 against 289.2526Q3

The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.

PeriodReportedEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mSurpriseYear-ago quarterAnalystsNext session
2026Q3ended 2026-09-302026-10-23 08:301.4601.4301.460290.66289.25EPS +2.1% · sales +0.5%vs 2025Q3, year-ago quarter · EPS +17.7% · sales +8.6%2 EPS · 3 salesOpen +1.50% vs SPY -0.53%. Close +2.18% vs SPY -0.52%
2026Q2ended 2026-06-302026-07-31 08:301.3901.2751.386284268.5EPS +9.0% · sales +5.8%vs 2025Q2, year-ago quarter · EPS +18.8% · sales +11.2%2 EPS · 3 salesOpen +0.28% vs SPY +0.40%. Close +2.97% vs SPY +0.72%
2026Q1ended 2026-03-312026-04-30 08:301.2501.2451.248270.71266.5EPS +0.4% · sales +1.6%vs 2025Q1, year-ago quarter · EPS +10.6% · sales +8.1%2 EPS · 3 salesOpen 0.00% vs SPY +0.43%. Close -6.76% vs SPY +0.99%
2025Q4ended 2025-12-312026-02-20 08:301.2101.1751.214263.62259.59EPS +3.0% · sales +1.6%vs 2024Q4, year-ago quarter · EPS +17.5% · sales +9.8%2 EPS · 3 salesOpen -0.27% vs SPY -0.32%. Close -2.11% vs SPY +0.72%
2025Q3ended 2025-09-302025-10-21 08:301.2401.1551.236267.56258.28EPS +7.4% · sales +3.6%vs 2024Q3, year-ago quarter · EPS +20.4% · sales +11.5%2 EPS · 3 salesOpen +0.31% vs SPY +0.02%. Close +4.06% vs SPY 0.00%
2025Q2ended 2025-06-302025-07-31 08:301.1701.1201.171255.47250.31EPS +4.5% · sales +2.1%vs 2024Q2, year-ago quarter · EPS +7.3% · sales +9.1%2 EPS · 3 salesOpen -1.37% vs SPY +0.79%. Close +0.25% vs SPY -0.38%
2025Q1ended 2025-03-312025-04-24 08:301.1301.0451.129250.52245.7EPS +8.1% · sales +2.0%vs 2024Q1, year-ago quarter · EPS +9.7% · sales +4.5%2 EPS · 3 salesOpen -1.32% vs SPY +0.24%. Close -2.60% vs SPY +2.10%
2024Q4ended 2024-12-312025-02-21 08:301.0301.0551.032240239.96EPS -2.4% · sales +0.0%vs 2023Q4, year-ago quarter · EPS +8.4% · sales +4.9%2 EPS · 3 salesOpen +3.50% vs SPY -0.04%. Close +1.48% vs SPY -1.71%
2024Q3ended 2024-09-302024-10-25 08:301.0301.1151.032239.94241.93EPS -7.6% · sales -0.8%vs 2023Q3, year-ago quarter · EPS -1.0% · sales +4.3%2 EPS · 3 salesOpen +9.61% vs SPY +0.39%. Close +3.19% vs SPY -0.03%
2024Q2ended 2024-06-302024-07-26 08:301.0901.0350.982234.08239.68EPS +5.3% · sales -2.3%vs 2023Q2, year-ago quarter · EPS +2.8% · sales +1.2%2 EPS · 3 salesOpen +2.13% vs SPY +0.72%. Close +3.42% vs SPY +1.12%
2024Q1ended 2024-03-312024-05-03 08:301.0300.9800.888239.66232.46EPS +5.1% · sales +3.1%vs 2023Q1, year-ago quarter · EPS +9.6% · sales +3.1%2Open +0.53% vs SPY +1.21%. Close +2.82% vs SPY +1.24%
2023Q4ended 2023-12-312024-02-16 08:300.9500.9300.821228.7234.66EPS +2.2% · sales -2.5%vs 2022Q4, year-ago quarter · EPS +1.1% · sales -1.6%2 EPS · 3 salesOpen +1.10% vs SPY -0.06%. Close +1.92% vs SPY -0.50%
2023Q3ended 2023-09-302023-10-27 08:301.0400.9700.895229.95237.08EPS +7.2% · sales -3.0%vs 2022Q3, year-ago quarter · EPS +4.0% · sales -5.9%2 EPS · 3 sales-
2023Q2ended 2023-06-302023-07-28 08:301.0600.8400.928231.25244.87EPS +26.2% · sales -5.6%vs 2022Q2, year-ago quarter · EPS -0.9% · sales -2.3%2 EPS · 3 sales-
2023Q1ended 2023-03-312023-04-28 08:300.9400.7200.701232.54233.52EPS +30.6% · sales -0.4%vs 2022Q1, year-ago quarter · EPS -8.7% · sales +1.6%2 EPS · 3 sales-
2022Q4ended 2022-12-312023-02-24 08:300.9400.8000.661232.53241.47EPS +17.5% · sales -3.7%vs 2021Q4, year-ago quarter · EPS +10.6% · sales +9.1%2 EPS · 3 sales-

Annual earnings

2025FY EPS 4.750 beat 4.713, from 3.930 a year earlier. Sales 1,037 beat 1,033, from 953.68 a year earlier
EPS
4.75002018FY EPS 3.010 against 2.85020182019FY EPS 3.190 against 2.69720192020FY EPS 3.320 against 2.76820202021FY EPS 3.570 against 3.27020212022FY EPS 4.030 against 3.69520222023FY EPS 4.000 against 3.73020232024FY EPS 3.930 against 3.98020242025FY EPS 4.750 against 4.7132025
Sales, USD millions
1,03702018FY sales 643.68 against 642.0220182019FY sales 643.71 against 642.7320192020FY sales 703.64 against 698.3820202021FY sales 799.02 against 784.0620212022FY sales 942.36 against 951.2720222023FY sales 922.44 against 928.4120232024FY sales 953.68 against 953.6420242025FY sales 1,037 against 1,0332025

Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.

earnings feed, not the snapshot. Not the statement ratio.

PeriodEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mP/E, earnings feed
2028FYestimate-5.900--1,26529.21
2027FYestimate-5.717--1,19930.15
2026FYestimate-5.480--1,13231.45
2025FY4.7504.7134.7501,0371,03332.29
2024FY3.9303.9803.927953.68953.6441.48
2023FY4.0003.7303.345922.44928.4137.19
2022FY4.0303.6953.253942.36951.2730.30
2021FY3.5703.2702.942799.02784.0647.23
2020FY3.3202.7682.604703.64698.3834.71
2019FY3.1902.6972.451643.71642.7331.86
2018FY3.0102.8502.422643.68642.0226.03
2017FY2.5302.4952.790594.79585.1431.86
2016FY2.5202.4931.750553.2553.7333.30
2015FY2.5102.2981.890552.49564.4368.67
2014FY2.2102.1051.690541.38531.777.99
2013FY1.4501.4701.450337.17342.1118.86
2012FY1.3201.3331.320310.39301.88130.57
2011FY1.2801.3201.280291.87300.5134.65
2010FY1.1201.1001.120255.07252.1153.88

Quarterly results

2026Q3 revenue 290.66, from 267.56 a year earlier. Operating margin 21.7%, from 20.5% a year earlier
Revenue, USD millions
290.6602024Q4 revenue 24024Q42025Q1 revenue 250.5225Q12025Q2 revenue 255.4725Q22025Q3 revenue 267.5625Q32025Q4 revenue 263.6225Q42026Q1 revenue 270.7126Q12026Q2 revenue 28426Q22026Q3 revenue 290.6626Q3
Operating margin
22.802024Q4 operating margin 19.7%24Q42025Q1 operating margin 20.6%25Q12025Q2 operating margin 20.3%25Q22025Q3 operating margin 20.5%25Q32025Q4 operating margin 22.8%25Q42026Q1 operating margin 20.9%26Q12026Q2 operating margin 20.9%26Q22026Q3 operating margin 21.7%26Q3

From the quarterly statement. Not an estimate.

Estimate revisions

Latest snapshot of each period and type. 2026FY E 5.48 per share.
PeriodTypeScaleDateMeanvs prior date
2026FYSUSD millions2026-10-291,132+0.0%
2026FYEper share2026-10-275.48+0.7%
2026FYRper share2026-10-275.48+0.7%
2026Q4S-2026-10-27286.91+0.0%
2026Q4Eper share2026-10-231.41+2.2%
2026Q4Rper share2026-10-231.41+2.2%
2026Q3S-2026-10-17289.250.0%
2026Q3Eper share2026-10-141.430.0%
2026Q3Rper share2026-10-141.430.0%
2026Q2Eper share2026-07-151.280.0%
2026Q2Rper share2026-07-151.280.0%
2026Q2S-2026-05-09268.50.0%
2026Q1S-2026-02-24266.5+0.3%
2026Q1Eper share2026-02-231.25-0.4%
2026Q1Rper share2026-02-231.25-0.4%
2025FYEper share2026-02-204.72+0.1%
2025FYRper share2026-02-204.72+0.1%
2025FYSUSD millions2026-02-201,030-0.2%
2025Q4S-2026-02-20261.46+0.7%
2025Q4Eper share2025-10-211.180.0%
2025Q4Rper share2025-10-211.180.0%
2025Q3S-2025-10-15258.280.0%
2025Q3Eper share2025-08-011.16+0.4%
2025Q3Rper share2025-08-011.16+0.4%
2025Q2Eper share2025-07-091.120.0%
2025Q2Rper share2025-07-091.120.0%
2025Q2S-2025-05-10250.310.0%
2025Q1S-2025-02-24245.7+0.3%
2025Q1Eper share2025-02-211.05-1.4%
2025Q1Rper share2025-02-211.05-1.4%
2024FYEper share2025-02-133.98+0.5%
2024FYRper share2025-02-133.98+0.5%
2024FYS-2025-02-13953.64-0.2%
2024Q4S-2025-02-13239.96-0.8%
2024Q4Rper share2025-01-151.060.0%
2024Q4Eper share2025-01-121.060.0%
2024Q3S-2024-10-13241.930.0%
2024Q3Eper share2024-10-091.120.0%
2024Q3Rper share2024-10-090.980.0%
2024Q2Eper share2024-07-201.040.0%
2024Q2Rper share2024-07-200.890.0%
2024Q2S-2024-07-20239.680.0%
2024Q1Rper share2024-05-010.910.0%
2024Q1S-2024-05-01232.460.0%
2024Q1Eper share2024-04-240.98-1.0%
2023FYEper share2024-01-253.73-7.9%
2023FYRper share2024-01-253.39-0.1%
2023FYS-2024-01-25928.41-0.1%

Estimate history

Annual
Metric201720182019202020212022202320242025TTMMRQ
EPS per share2.792.4222.4512.6042.9423.2533.3453.9274.7495.3058-
Sales USD millions5956446447047999429229541,0371,109-
Shares million shares323232323232323332-32
Quarterly
MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
EPS per share1.0321.0321.1291.1711.2361.2141.2481.3861.459
Sales USD millions240240251255268264271284291
Shares million shares333333323232323232

Income statement, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/2018
Total Revenue1,108.981,037.16+8.8%953.68+3.4%922.44-2.1%942.36+17.9%799.02+13.6%703.64+9.3%643.71+0.0%643.68
Cost of Goods Sold Incl. D&A704.60666.53+7.9%617.48-0.5%620.38-6.3%661.91+19.1%555.85+15.9%479.75+11.0%432.34-1.6%439.43
Gross Profit404.38370.63+10.2%336.21+11.3%302.06+7.7%280.45+15.3%243.17+8.6%223.90+5.9%211.37+3.5%204.25
Selling, General and Administrative Excl. Other165.53152.30+0.2%152.00+22.6%123.95-6.5%132.50+15.0%115.22+6.2%108.46+1.8%106.54+12.5%94.72
Research and Development20.8118.51+10.2%16.79+11.6%15.05+23.5%12.19-9.8%13.52+30.9%10.33-9.2%11.38-1.8%11.59
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income238.85218.33+18.5%184.21+3.4%178.10+20.4%147.96+15.6%127.95+10.8%115.44+10.1%104.83-4.3%109.54
Interest Expense7.9910.22-38.2%16.53-30.3%23.73+89.5%12.52+165.8%4.71-29.8%6.71-8.3%7.32+1.0%7.25
Unusual Expense9.279.01+593.1%1.30-93.1%18.91+582.7%2.77+515.6%0.45-89.5%4.29+89.0%2.27+5.6%2.15
Net Income Before Taxes220.38199.03+19.6%166.45+21.3%137.26+2.6%133.75+6.8%125.23+17.7%106.42+10.3%96.48-2.6%99.03
Income Taxes49.5344.19+16.4%37.98+32.2%28.72+1.2%28.38-2.6%29.13+33.7%21.79+29.6%16.81-17.8%20.46
Consolidated Net Income170.85154.84+20.5%128.47+18.4%108.54+3.0%105.37+9.6%96.10+13.6%84.62+6.2%79.67+1.4%78.57
Net Income From Continuing Operations170.85154.84+20.5%128.47+18.4%108.54+3.0%105.37+9.6%96.10+13.6%84.62+6.2%79.67+1.4%78.57
Net Income170.85154.84+20.5%128.47+18.4%108.54+3.0%105.37+9.6%96.10+13.6%84.62+6.2%79.67+1.4%78.57
EPS (Recurring) per share5.544.94+25.1%3.95+5.3%3.75+13.3%3.31+12.2%2.95+9.3%2.70+8.0%2.50+1.2%2.47
EPS (Basic, Before Extraordinaries) per share5.364.80+20.9%3.97+17.5%3.38+2.7%3.29+10.4%2.98+13.3%2.63+6.0%2.48+1.2%2.45
EPS (Diluted) per share5.314.75+20.9%3.93+17.3%3.35+3.1%3.25+10.5%2.94+13.1%2.60+6.1%2.45+1.2%2.42
EBITDA287.17263.52+13.8%231.66-0.4%232.51+16.7%199.26+14.7%173.71+5.6%164.44+9.3%150.41-2.0%153.52
Non-Operating Income (Expense)-1.21-0.08-214.3%0.07-96.1%1.80+66.7%1.08-55.7%2.44+23.2%1.98+59.7%1.24-1.11
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense14.8814.27+8.4%13.17+3.9%12.68+21.3%10.45+32.4%7.89+70.8%4.62-16.8%5.55+9.5%5.07
Price To Earnings Ratio ratio statement ratio, not the snapshot32.4832.4843.7846.7036.4057.3144.2641.4532.29
Price To Sales Ratio ratio4.764.825.595.234.206.895.325.133.95
Gross Margin %36.4635.7435.2532.7529.7630.4331.8232.8431.73
Operating Margin %21.5421.0519.3219.3115.7016.0116.4116.2817.02
Net Margin %15.4114.9313.4711.7711.1812.0312.0312.3812.21
Shares Outstanding million shares31.8232.06-1.4%32.53+0.9%32.25+0.3%32.15-0.4%32.29-0.2%32.37+0.5%32.20-0.2%32.26
Market Capitalization5,476.825,476.82+3.4%5,298.59+10.5%4,795.86+22.2%3,924.02-28.1%5,459.54+46.5%3,727.49+14.0%3,269.34+29.4%2,526.63

Income statement, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Total Revenue290.66+8.6%284.00+11.2%270.71+8.1%263.62+9.8%267.56+11.5%255.47+9.1%250.52+4.5%240.00+4.9%
Cost of Goods Sold Incl. D&A184.94+7.5%180.31+11.1%169.62+4.5%169.72+10.4%172.10+11.3%162.35+7.5%162.35+2.7%153.670.0%
Gross Profit105.71+10.7%103.68+11.4%101.08+14.6%93.90+8.8%95.45+11.8%93.11+12.2%88.17+8.2%86.34+15.1%
Selling, General and Administrative Excl. Other42.70+5.3%44.44+7.7%44.56+21.5%33.83-13.6%40.54+9.1%41.27+11.4%36.66-7.0%39.17+157.5%
Research and Development5.34+18.7%4.53+5.3%5.88+26.2%5.05+12.0%4.50+3.9%4.30+11.7%4.66+13.7%4.51+14.5%
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income63.02+14.8%59.24+14.3%56.52+9.7%60.07+27.3%54.91+13.9%51.85+12.9%51.50+22.3%47.17-21.1%
Interest Expense1.93-26.6%1.94-30.0%2.21-24.3%1.90-32.6%2.63-35.4%2.77-34.7%2.92-45.9%2.82-46.7%
Unusual Expense0.58+75.8%0.02-95.1%0.90+83.7%7.780.33+50.0%0.41+215.4%0.49+11.4%-0.27-101.3%
Net Income Before Taxes60.04+15.4%57.78+17.9%52.52+9.6%50.03+12.5%52.04+18.6%49.01+18.9%47.94+30.1%44.48+33.7%
Income Taxes13.32+13.3%13.17+22.7%12.24+12.4%10.81-0.8%11.76+16.9%10.73+17.1%10.89+38.5%10.90+64.7%
Consolidated Net Income46.73+16.0%44.62+16.6%40.28+8.7%39.23+16.8%40.29+19.1%38.28+19.4%37.05+27.8%33.58+26.0%
Net Income From Continuing Operations46.73+16.0%44.62+16.6%40.28+8.7%39.23+16.8%40.29+19.1%38.28+19.4%37.05+27.8%33.58+26.0%
Net Income46.73+16.0%44.62+16.6%40.28+8.7%39.23+16.8%40.29+19.1%38.28+19.4%37.05+27.8%33.58+26.0%
EPS (Recurring) per share1.47+18.5%1.39+17.8%1.27+11.4%1.38+34.0%1.24+19.2%1.18+19.2%1.14+26.7%1.03-19.5%
EPS (Basic, Before Extraordinaries) per share1.47+17.6%1.40+18.6%1.26+10.5%1.22+18.4%1.25+19.0%1.18+19.2%1.14+26.7%1.03+24.1%
EPS (Diluted) per share1.46+17.7%1.39+18.8%1.25+10.6%1.21+17.5%1.24+20.4%1.17+19.4%1.13+27.0%1.03+25.6%
EBITDA75.40+13.5%71.46+13.0%69.01+10.4%71.29+23.9%66.46+12.4%63.25+8.2%62.52+12.1%57.55-21.5%
Non-Operating Income (Expense)-0.46-611.1%0.50+47.1%-0.89-0.350.090.34-0.15-126.3%-0.14-163.6%
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense3.98+8.4%4.68+1.5%3.25+40.7%2.97-3.3%3.67+11.9%4.61+50.2%2.31-38.4%3.07+2.7%
Price To Earnings Ratio ratio statement ratio, not the snapshot32.4834.7035.6833.5734.3838.1342.1943.78
Price To Sales Ratio ratio4.765.015.174.784.835.285.655.56
Gross Margin %36.3736.5137.3435.6235.6836.4535.1935.97
Operating Margin %21.6820.8620.8822.7920.5220.2920.5619.65
Net Margin %16.0815.7114.8814.8815.0614.9814.7913.99
Shares Outstanding million shares31.82-1.7%31.96-1.5%32.13-1.5%32.06-1.4%32.38-0.4%32.46+0.1%32.61+0.6%32.53+0.9%
Market Capitalization5,476.82+12.5%5,428.33+4.5%5,427.66+0.5%4,966.76-6.3%4,870.23-14.7%5,192.67+4.0%5,400.43+8.0%5,298.59+10.5%

Balance sheet, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/20182017FY12/31/2017
Cash & Short Term Investments74.57+50.6%49.52-23.2%64.45-3.2%66.56-35.5%103.24+22.1%84.57+28.8%65.67+21.0%54.27+34.3%40.42
Short Term Receivables143.60+20.0%119.66-4.5%125.28-4.8%131.58+12.1%117.41+19.5%98.21+5.1%93.44-6.1%99.55+9.1%91.23
Inventories131.45+0.5%130.80+19.4%109.52-8.5%119.67+31.4%91.06+28.9%70.62-15.8%83.89+24.9%67.19+10.7%60.70
Other Current Assets16.00+16.0%13.79-8.0%14.99-16.7%18.00+70.9%10.53-21.9%13.48+12.9%11.94+124.9%5.31-24.1%7.00
Total Current Assets365.61+16.5%313.77-0.1%314.24-6.4%335.80+4.2%322.23+20.7%266.89+4.7%254.95+12.7%226.31+13.5%199.34
Net Property, Plant & Equipment322.84+7.9%299.20+1.1%295.90+1.8%290.79+17.8%246.81+4.4%236.51+5.5%224.20+15.4%194.34+2.4%189.79
Total Investments and Advances3.72-3.6%3.86-5.4%4.08-4.9%4.29-4.7%4.50-9.5%4.97+10.2%4.51-8.0%4.90+2.1%4.80
Intangible Assets979.66+3.7%945.08-2.6%970.12-1.3%982.80+58.9%618.61-5.0%651.12-2.5%667.92+20.6%553.98-2.7%569.43
Deferred Tax Assets21.31-28.2%29.68+6.3%27.93+53.1%18.24+70.6%10.69-17.6%12.98+10.6%11.74+52.3%7.71-
Other Assets14.42+7.1%13.46+4.6%12.87+18.9%10.82+50.9%7.17+12.7%6.36+55.1%4.10+125.3%1.82+574.1%0.27
Total Assets1,707.56+6.4%1,605.05-1.2%1,625.14-1.1%1,642.75+35.8%1,210.02+2.6%1,178.83+1.0%1,167.42+18.0%989.07+2.6%963.64
Short Term Debt Incl. Current Port. of LT Debt3.82+14.7%3.33-21.1%4.22+5.0%4.02+70.3%2.36+0.9%2.34-5.6%2.480.00-100.0%35.00
Accounts Payable60.42+10.4%54.74-1.4%55.50-3.2%57.32+1.9%56.24+136.9%23.74-36.3%37.27+10.3%33.79+18.8%28.45
Income Tax Payable3.91-12.5%4.47-10.1%4.97+118.0%2.28+71.4%1.33-0.00--
Other Current Liabilities108.23+13.7%95.15+13.5%83.80+9.7%76.42-8.9%83.86+22.7%68.35+30.1%52.52+8.8%48.27+7.4%44.95
Total Current Liabilities176.38+11.9%157.69+6.2%148.49+6.0%140.04-2.6%143.80+52.3%94.43+2.4%92.26+12.4%82.06-24.3%108.40
Long Term Debt176.87-13.6%204.72-37.2%326.11-28.6%456.59+294.7%115.68-31.8%169.65-33.1%253.40+62.4%156.00-15.2%183.96
Provision for Risks Charges1.99-6.6%2.13+17.7%1.81-2.7%1.86-73.2%6.95+53.4%4.53+171.3%1.670.000.00
Deferred Tax Liabilities75.45+2.8%73.40-8.2%79.98-1.3%81.02+41.8%57.15-11.2%64.34-5.6%68.17+31.0%52.02-2.5%53.33
Other Liabilities19.45+13.1%17.20+16.5%14.76-40.9%24.96+165.0%9.42-46.6%17.64+113.6%8.26+12.1%7.37+588.8%1.07
Total Liabilities450.15-1.1%455.14-20.3%571.16-18.9%704.47+111.6%333.00-5.0%350.59-17.3%423.76+42.5%297.45-14.2%346.75
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity1,257.41+9.3%1,149.91+9.1%1,053.98+12.3%938.28+7.0%877.01+5.9%828.23+11.4%743.67+7.5%691.62+12.1%616.88
Total Shareholders Equity1,257.41+9.3%1,149.91+9.1%1,053.98+12.3%938.28+7.0%877.01+5.9%828.23+11.4%743.67+7.5%691.62+12.1%616.88
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity1,257.41+9.3%1,149.91+9.1%1,053.98+12.3%938.28+7.0%877.01+5.9%828.23+11.4%743.67+7.5%691.62+12.1%616.88
Total Liabilities & Stockholders Equity1,707.56+6.4%1,605.05-1.2%1,625.14-1.1%1,642.75+35.8%1,210.02+2.6%1,178.83+1.0%1,167.42+18.0%989.07+2.6%963.64
Book Value Per Share per share39.22+10.9%35.35+8.2%32.68+12.0%29.18+7.4%27.16+6.2%25.58+10.8%23.09+7.7%21.44+11.3%19.27
Tangible Book Value Per Share per share8.66+37.5%6.30+142.3%2.60-1.38-117.2%8.00+46.3%5.47+132.8%2.35-45.0%4.27+188.5%1.48
Full-Time Employees people1,352-0.7%1,361+4.5%1,302-2.8%1,340+1.7%1,317-1.9%1,342-5.8%1,424+25.5%1,135-2.6%1,165
Price to Book Ratio ratio4.134.504.684.406.214.504.403.654.40
Return on Assets %9.357.956.647.398.057.217.398.059.42
Return on Equity %12.8611.6610.9011.6111.2710.7711.1012.0115.83
Return on Invested Capital %10.809.487.867.559.688.487.999.2711.25
Quick Ratio ratio1.331.161.381.541.612.081.851.941.28
Current Ratio ratio2.071.992.122.402.242.832.762.761.84

Cash flow, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/2018
Net Income170.85154.84+20.5%128.47+18.4%108.54+3.0%105.37+9.6%96.10+13.6%84.62+6.2%79.67+1.4%78.57
Depreciation47.9044.77-4.6%46.95-12.6%53.72+12.1%47.92+4.7%45.76-6.6%49.00+7.5%45.58+3.6%43.99
Other Funds (Non Cash)25.4818.15-6.8%19.48+58.4%12.30-34.7%18.83+37.7%13.67+5.5%12.96+67.7%7.73+39.3%5.55
Funds from Operations249.91224.02+19.1%188.12+14.9%163.750.0%163.76+9.5%149.58+5.4%141.96+9.7%129.42+5.5%122.71
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-26.09-7.46-6.12-130.6%20.01-25.22-330.7%10.93+28.1%8.53-4.96-4.01
Income Taxes Payable-4.19-1.07-0.58-126.5%2.19+630.0%0.30-93.7%4.79+157.5%1.86-5.66-605.4%1.12
Cash from Operating Activities223.82216.56+19.0%182.00-1.0%183.76+32.6%138.54-13.7%160.51+6.7%150.49+20.9%124.46+4.9%118.70
Capital Expenditures-45.82-43.49-35.66-37.89-50.29-37.45-33.83-28.41-19.72
Net Assets From Acquisitions0.00-0.32-24.16-1.25-365.780.000.00-141.06-17.40
Sale of Fixed Assets and Businesses0.010.27-25.0%0.36-80.9%1.88+795.2%0.21-34.4%0.32+255.6%0.09-99.2%11.52+1087.6%0.97
Purchase or Sale of Investments-0.36-0.35-0.27-111.0%2.450.000.000.000.000.00
Purchase of Investments-0.36-0.35-0.27-0.290.000.000.000.00-
Sale Or Maturity of Investments0.000.000.00-100.0%2.740.000.000.000.000.00
Other Uses0.000.000.000.00-0.150.00-0.85-1.000.00
Other Sources0.000.000.000.000.00-100.0%1.830.00-100.0%2.73-34.5%4.17
Cash from Investing Activities-46.17-43.89-59.74-34.81-416.01-35.30-34.59-156.22-31.99
Cash Dividends Paid-30.78-28.29-25.58-22.87-20.71-18.72-16.70-15.13-13.43
Change in Capital Stock-111.52-98.33-951.3%11.55+1400.0%0.77-32.21-28.30-4201.4%0.69-16.48-339.5%6.88
Repurchase of Common Pref Stock-125.55-107.64-5.68-4.47-35.42-35.24-13.46-21.32-1.39
Sale of Common Pref Stock14.039.31-46.0%17.23+228.8%5.24+63.2%3.21-53.7%6.94-51.0%14.15+192.4%4.84-41.5%8.27
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-32.15-26.19-119.78-131.22-143.8%299.60-55.16-85.15-213.5%75.00-64.89
Change in Long Term Debt-32.15-26.19-119.78-131.22-143.8%299.60-55.16-85.15-213.5%75.00-64.89
Issuance of Long Term Debt104.0688.00+238.5%26.00+44.4%18.00-95.9%433.77+8575.4%5.00-50.0%10.00-94.1%168.57-19.5%209.38
Reduction of Long Term Debt-136.20-114.19-145.78-149.22-134.16-60.16-95.15-93.57-274.27
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities-174.45-152.81-133.81-153.32-162.2%246.68-102.18-101.16-333.2%43.38-71.45
Exchange Rate Effect-2.035.20-3.38-249.6%2.26-5.88-4.37-205.0%4.16-0.22-1.41
Net Change in Cash1.1725.05-14.93-2.11-36.68-296.5%18.67-1.2%18.90+65.8%11.40-17.7%13.85
Free Cash Flow178.00173.07+18.3%146.34+0.3%145.87+65.3%88.25-28.3%123.06+5.5%116.67+21.5%96.05-3.5%99.53
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow ratio35.8934.5444.1639.2458.5752.7937.4640.8329.53
Deferred Taxes & Investment Tax Credit-6.26-6.78-10.81-8.36-5.94-4.63-3.56-5.40

Balance sheet, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Cash & Short Term Investments66.26+1.8%63.17-3.5%72.87+46.0%74.57+50.6%65.09-11.7%65.43+2.7%49.90-17.3%49.52-23.2%
Short Term Receivables145.63+10.7%148.97+9.6%154.23+18.2%143.60+20.0%131.54+9.1%135.98+10.2%130.48-6.7%119.66-4.5%
Inventories177.01+33.7%161.55+9.0%146.74+1.2%131.45+0.5%132.44+11.8%148.15+26.5%144.93+31.3%130.80+19.4%
Other Current Assets15.97+9.1%14.73-3.7%15.09+1.1%16.00+16.0%14.64+10.5%15.30-3.9%14.93+4.8%13.79-8.0%
Total Current Assets404.88+17.8%388.42+6.5%388.94+14.3%365.61+16.5%343.71+5.4%364.86+14.0%340.24+4.7%313.77-0.1%
Net Property, Plant & Equipment323.82+2.7%318.82+3.7%318.20+5.7%322.84+7.9%315.33+7.0%307.37+5.6%301.03+2.7%299.20+1.1%
Total Investments and Advances3.49-3.9%3.56-4.3%3.63-3.5%3.72-3.6%3.63-5.0%3.72-4.9%3.76-6.0%3.86-5.4%
Intangible Assets954.85-3.0%960.45-2.8%967.91+0.9%979.66+3.7%983.95+2.6%988.26+4.5%959.05+0.6%945.08-2.6%
Deferred Tax Assets---21.31-28.2%---29.68+6.3%
Other Assets16.53+14.8%15.74+12.0%15.05+11.7%14.42+7.1%14.40+4.8%14.05+1.9%13.47+1.9%13.46+4.6%
Total Assets1,703.57+2.6%1,687.00+0.5%1,693.74+4.7%1,707.56+6.4%1,661.03+4.0%1,678.25+6.6%1,617.56+1.8%1,605.05-1.2%
Short Term Debt Incl. Current Port. of LT Debt3.98-3.9%3.38-12.7%3.65-6.9%3.82+14.7%4.14+21.8%3.87+0.8%3.92-3.2%3.33-21.1%
Accounts Payable72.04+53.3%70.45+3.8%70.73+7.2%60.42+10.4%46.98+1.1%67.86+24.5%65.97+10.3%54.74-1.4%
Income Tax Payable2.38-63.1%0.00-100.0%13.47-1.9%3.91-12.5%6.45+229.1%0.57-83.4%13.73+16.1%4.47-10.1%
Other Current Liabilities85.72+24.6%71.92+9.3%64.69+15.7%108.23+13.7%68.79+19.4%65.83+27.7%55.93+14.8%95.15+13.5%
Total Current Liabilities164.12+29.9%145.75+5.5%152.54+9.3%176.38+11.9%126.37+15.5%138.14+21.9%139.56+12.2%157.69+6.2%
Long Term Debt138.47-17.5%163.33-19.9%181.06-11.3%176.87-13.6%167.85-30.6%203.81-27.7%204.14-35.7%204.72-37.2%
Provision for Risks Charges2.08-10.7%2.04-10.1%2.00-6.5%1.99-6.6%2.33+30.2%2.27+31.2%2.14+25.9%2.13+17.7%
Deferred Tax Liabilities52.27+9.8%52.94+10.8%53.38+18.0%75.45+2.8%47.60-5.7%47.77-12.7%45.22-18.8%73.40-8.2%
Other Liabilities19.85+4.4%20.56+12.0%19.65+10.4%19.45+13.1%19.01+17.7%18.35+70.7%17.80+67.3%17.20+16.5%
Total Liabilities376.80+3.8%384.63-6.3%408.63-0.1%450.15-1.1%363.17-13.5%410.33-11.3%408.85-19.8%455.14-20.3%
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity1,326.78+2.2%1,302.38+2.7%1,285.12+6.3%1,257.41+9.3%1,297.86+10.2%1,267.91+14.0%1,208.70+12.0%1,149.91+9.1%
Total Shareholders Equity1,326.78+2.2%1,302.38+2.7%1,285.12+6.3%1,257.41+9.3%1,297.86+10.2%1,267.91+14.0%1,208.70+12.0%1,149.91+9.1%
Accumulated Minority Interest0.000.000.000.000.000.000.000.00
Total Equity1,326.78+2.2%1,302.38+2.7%1,285.12+6.3%1,257.41+9.3%1,297.86+10.2%1,267.91+14.0%1,208.70+12.0%1,149.91+9.1%
Total Liabilities & Stockholders Equity1,703.57+2.6%1,687.00+0.5%1,693.74+4.7%1,707.56+6.4%1,661.03+4.0%1,678.25+6.6%1,617.56+1.8%1,605.05-1.2%
Book Value Per Share per share41.69+4.0%40.76+4.3%40.00+7.9%39.22+10.9%40.09+10.7%39.07+13.9%37.06+11.4%35.35+8.2%
Tangible Book Value Per Share per share11.69+20.5%10.70+24.1%9.87+28.9%8.66+37.5%9.70+44.3%8.62+68.0%7.66+98.4%6.30+142.3%
Full-Time Employees people1,430+5.5%--1,352-0.7%1,3551,3641,3791,361+4.5%
Price to Book Ratio ratio4.134.224.323.833.844.304.704.50
Return on Assets %10.169.779.559.359.168.788.527.95
Return on Equity %13.0212.7912.6812.8612.0611.9911.9411.66
Return on Invested Capital %3.193.042.752.732.752.602.622.48
Quick Ratio ratio1.391.561.591.331.671.571.401.16
Current Ratio ratio2.472.662.552.072.722.642.441.99

Cash flow, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Net Income46.73+16.0%44.62+16.6%40.28+8.7%39.23+16.8%40.29+19.1%38.28+19.4%37.05+27.8%33.58+26.0%
Depreciation12.39+7.3%12.22+7.2%12.49+13.4%10.80+9.4%11.55+6.0%11.40-8.9%11.01-19.5%9.87-23.1%
Other Funds (Non Cash)7.48+74.0%6.22+30.7%6.51+70.4%5.27-9.0%4.30-14.7%4.76+4.8%3.82-6.8%5.79+50.4%
Funds from Operations66.09+18.0%62.89+15.5%59.10+14.2%61.82+39.3%55.99+14.3%54.43+12.7%51.77+11.5%44.38+27.0%
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital3.68-61.6%-16.18-19.045.45-31.3%9.58+311.2%-7.18-15.317.93-75.6%
Income Taxes Payable3.15-46.2%-14.329.49+4.1%-2.51-199.2%5.85-13.539.12+31.6%2.53-74.5%
Cash from Operating Activities69.77+6.4%46.71-1.1%40.06+9.9%67.28+28.6%65.57+27.8%47.25+5.0%36.46+9.2%52.32-22.4%
Capital Expenditures-12.47-10.89-6.25-16.21-14.90-6.81-5.56-12.72
Net Assets From Acquisitions0.000.000.000.000.000.00-0.32-24.16
Sale of Fixed Assets and Businesses0.000.01-96.3%0.000.01-88.9%0.000.27+350.0%0.00-100.0%0.09
Purchase or Sale of Investments-0.06-0.05-0.04-0.21-0.04-0.07-0.03-0.16
Purchase of Investments-0.06-0.05-0.04-0.21-0.04-0.07-0.03-0.16
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.00
Cash from Investing Activities-12.53-10.93-6.29-16.42-14.94-6.62-5.91-36.96
Cash Dividends Paid-0.00-0.00-30.77-0.01-0.01-0.00-28.26-0.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.000.000.00
Change in Capital Stock-23.59-27.78-8.96-51.19-2882.1%-14.77-381.9%-28.71-3362.5%-3.66-201.9%1.84+102.2%
Repurchase of Common Pref Stock-27.44-28.79-15.69-53.63-15.42-33.26-5.33-0.31
Sale of Common Pref Stock3.85+492.3%1.01-77.8%6.73+303.0%2.44+14.0%0.65-88.0%4.55+411.2%1.67-81.0%2.14+58.5%
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-29.99-17.054.959.95-36.05-0.05-0.05-37.05
Change in Long Term Debt-29.99-17.054.959.95-36.05-0.05-0.05-37.05
Issuance of Long Term Debt6.06-13.4%28.00-17.6%52.00+79.3%18.007.0034.0029.00+11.5%0.00
Reduction of Long Term Debt-36.05-45.05-47.05-8.05-43.05-34.05-29.05-37.05
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.00
Cash from Financing Activities-53.59-44.83-34.78-41.25-50.83-28.76-31.97-35.21
Exchange Rate Effect-0.57-0.64-117.5%-0.68-137.6%-0.13-0.13-105.8%3.651.81-4.32-305.7%
Net Change in Cash3.09-9.70-162.5%-1.70-535.9%9.48-0.33-103.3%15.53+358.1%0.39-24.18
Free Cash Flow57.30+13.1%35.83-11.4%33.81+9.4%51.06+29.0%50.67+20.2%40.44+6.1%30.90+16.7%39.59-29.1%
Price to Free Cash Flow ratio35.8938.7037.6934.2436.6941.6944.4743.93

Revenue breakdown

USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.

Product
Name20242025vs 20242025 share
Product Sales951.951,035.27+8.8%99.8%
Royalty1.741.89+8.8%0.2%
Total953.681,037.16+8.8%100.0%
Region
Name20242025vs 20242025 share
Non-US230.38277.71+20.5%26.8%
United States723.30759.45+5.0%73.2%
Total953.681,037.16+8.8%100.0%
Segment
Name20242025vs 20242025 share
Animal Nutrition and Health214.71230.85+7.5%22.3%
Consolidation, Policy5.975.95-0.4%0.6%
Human Nutrition and Health600.26659.39+9.9%63.6%
Specialty Products132.75140.98+6.2%13.6%
Total953.681,037.16+8.8%100.0%

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-301.59%0.5M31.6M232.20K
2026-10-151.63%0.5M31.7M206.51K
2026-09-301.56%0.5M31.7M201.78K
2026-09-151.96%0.6M31.7M216.13K
2026-08-311.75%0.6M31.7M221.33K
2026-08-141.91%0.6M31.7M221.86K
2026-07-311.74%0.6M31.7M222.33K
2026-07-151.89%0.6M32.0M232.69K
2026-06-301.62%0.5M32.0M220.77K
2026-06-151.31%0.4M31.9M206.42K
2026-05-291.30%0.4M32.0M197.30K
2026-05-151.17%0.4M31.9M200.47K
2026-04-301.08%0.3M31.9M199.50K
2026-04-151.08%0.3M31.8M183.44K
2026-03-311.20%0.4M31.8M180.00K
2026-03-131.24%0.4M31.8M180.33K
2026-02-271.06%0.3M31.8M181.04K
2026-02-130.88%0.3M31.8M179.75K
2026-01-300.91%0.3M32.2M177.81K
2026-01-151.08%0.3M32.2M184.90K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call10565.3069.500.00253.7%0.000.000.916-0.7300.039
call11060.3064.500.00242.9%0.000.000.909-0.7160.041
call11555.3059.500.00215.5%0.000.000.902-0.7000.044
call12050.3054.500.00197.5%0.000.000.894-0.6830.046
call12545.3049.500.00180.0%0.000.000.885-0.6640.049
call13040.5044.500.00169.8%0.000.000.875-0.6430.052
call13535.5039.500.00146.5%0.000.000.857-0.6560.057
call14030.5034.500.00130.2%0.000.000.843-0.6280.061
call14525.5029.500.00114.3%0.000.000.826-0.5970.065
call15020.5024.6032.60100.1%1.000.000.805-0.5610.070
call15515.5019.600.0084.0%0.000.000.778-0.5190.075
call16010.8014.800.0070.5%0.000.000.746-0.4510.081
call1656.1010.1010.4056.8%2.000.000.695-0.3800.088
call1701.705.005.9636.3%3.000.000.600-0.2890.098
call1750.004.303.5750.9%56.000.000.428-0.2980.099
call1800.004.901.3069.4%22.000.000.339-0.3770.092
call1850.004.900.7579.6%24.000.000.285-0.4240.086
call1900.004.900.65103.1%17.000.000.286-0.5690.086
call1950.004.902.18116.3%49.000.000.263-0.6150.082
call2000.004.900.18128.7%1.000.000.245-0.6550.079
call2100.003.700.00138.7%0.000.000.193-0.6140.069
call2200.003.702.25158.2%1.000.000.175-0.6600.065
call2300.003.701.35176.2%1.000.000.162-0.6990.062
call2400.003.700.00192.8%0.000.000.152-0.7320.059
put1050.003.700.85290.8%1.000.00-0.084-0.7220.039
put1100.003.700.95269.4%2.000.00-0.091-0.7070.041
put1150.003.701.30248.8%3.000.00-0.098-0.6900.044
put1200.003.700.85229.0%4.000.00-0.106-0.6730.046
put1250.003.700.95209.7%7.000.00-0.115-0.6530.049
put1300.003.701.15191.0%8.000.00-0.125-0.6320.052
put1350.004.900.90178.1%3.000.00-0.142-0.6440.057
put1400.004.901.15159.9%10.000.00-0.157-0.6160.061
put1450.004.902.70141.9%2.000.00-0.174-0.5840.065
put1500.004.900.00124.0%0.000.00-0.195-0.5480.070
put1550.004.900.00103.4%0.000.00-0.217-0.4860.074
put1600.004.901.6087.9%14.000.00-0.256-0.4440.081
put1650.003.709.9069.0%1.000.00-0.305-0.3650.088
put1700.004.000.8051.4%2.002.00-0.408-0.3100.098
put1752.255.501.0140.6%37.000.00-0.568-0.2960.099
put1805.9010.007.0052.8%2.000.00-0.650-0.3880.093
put18510.7014.6018.0862.5%0.000.00-0.691-0.4700.089
put19015.6019.600.0075.3%0.000.00-0.714-0.5510.086
put19520.6024.6024.5087.2%0.000.00-0.737-0.5960.082
put20025.6029.600.0098.2%0.000.00-0.755-0.6360.079
put21035.6039.800.00121.8%0.000.00-0.807-0.5940.069
put22045.6049.800.00140.4%0.000.00-0.825-0.6390.065
put23055.6059.800.00157.5%0.000.00-0.838-0.6760.062
put24065.6069.700.00171.4%0.000.00-0.848-0.7080.059

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-2310-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-238-KCurrent report2026-10-23SEC
2026-09-243Initial statement of beneficial ownership of securities2026-09-16SEC
2026-07-3110-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-318-KCurrent report2026-07-31SEC
2026-07-278-KCurrent report2026-07-24SEC
2026-06-228-KCurrent report2026-06-18SEC
2026-06-1811-KAnnual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)2025-12-31SEC
2026-04-3010-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-04-308-KCurrent report2026-04-30SEC
2026-04-29SCHEDULE 13GSEC
2026-04-28SCHEDULE 13GSEC
2026-04-27DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-27DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-18SEC
2026-04-073Initial statement of beneficial ownership of securities2026-04-01SEC
2026-03-26SCHEDULE 13G/ASEC
2026-02-2010-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-02-208-KCurrent report2026-02-20SEC
2026-02-198-KCurrent report2026-02-12SEC
2026-02-134Statement of changes in beneficial ownership of securities2026-02-11SEC
2026-02-134Statement of changes in beneficial ownership of securities2026-02-11SEC
2026-02-134Statement of changes in beneficial ownership of securities2026-02-11SEC
2026-02-134Statement of changes in beneficial ownership of securities2026-02-11SEC
2026-02-134Statement of changes in beneficial ownership of securities2026-02-11SEC
2026-02-134Statement of changes in beneficial ownership of securities2026-02-11SEC
2026-02-134Statement of changes in beneficial ownership of securities2026-02-11SEC
2026-02-134Statement of changes in beneficial ownership of securities2026-02-11SEC
2026-02-134Statement of changes in beneficial ownership of securities2026-02-11SEC
2026-02-134Statement of changes in beneficial ownership of securities2026-02-11SEC
2026-02-134Statement of changes in beneficial ownership of securities2026-02-11SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-12002.15M2
2025-1100185.33K1

Institutional holders

Manager% owned
BlackRock, Inc.15.45%
VANGUARD PORTFOLIO MANAGEMENT LLC6.91%
VANGUARD CAPITAL MANAGEMENT LLC4.50%
STATE STREET CORP4.01%
GEODE CAPITAL MANAGEMENT, LLC3.52%
Conestoga Capital Advisors, LLC2.68%
MORGAN STANLEY2.60%
DIMENSIONAL FUND ADVISORS LP2.00%
WASATCH ADVISORS LP1.98%
FIRST TRUST ADVISORS LP1.92%

Funds

Fund% owned
iShares Core S&P Small-Cap ETF6.02%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.17%
iShares Russell 2000 ETF2.63%
VANGUARD SMALL-CAP INDEX FUND2.29%
First Trust SMID Cap Rising Dividend Achievers ETF1.76%
CONESTOGA SMALL CAP FUND1.58%
VANGUARD SMALL-CAP GROWTH INDEX FUND1.32%
VANGUARD EXTENDED MARKET INDEX FUND1.15%
Fidelity Small Cap Index Fund1.11%
State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF0.92%

OakChart. BCPC. Cached 15 minutes. Terms